[1. J. P. Meyer, J. T. Pelton, J. Hoflack and V. Saudek, Solution structure of salmon calcitonin, Biopolymers31 (1991) 233–241; DOI: 10.1002/bip.360310210.10.1002/bip.3603102102043752]Search in Google Scholar
[2. C. L. Stevenson, Advances in peptide pharmaceuticals, Cur. Pharm. Biotechnol.10 (2009) 122–137; DOI: 10.2174/138920109787048634.10.2174/13892010978704863419149594]Search in Google Scholar
[3. L. Jorgensen, E. H. Moeller, M. Van de Weert, H. M. Nielsen and S. Frokjaer, Preparing and evaluating delivery systems for proteins, Eur. J. Pharm. Sci.29 (2006) 174–182; DOI: 10.1016/j.eps.2006.05.008.]Search in Google Scholar
[4. Z. Antosova, M. Mackova, V. Kral and T. Macek, Therapeutic application of peptides and proteins: parenteral forever? Trends Biotech.27 (2009) 628–635; DOI: 10.1016/j.tibtech.2009.07.009.10.1016/j.tibtech.2009.07.00919766335]Search in Google Scholar
[5. A. Makhlof, M. Werle, Y, Tozuka and H. Takeuchi, Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin, Int. J. Pharm.397 (2010) 92–95; DOI: 10.1016/j.ijpharm.2010.07.00.]Search in Google Scholar
[6. H. Yamamoto, Y. Kuno, S. Sugimoto, H. Takeuchi and Y. Kawashima, Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions, J. Control. Release102 (2005) 373–381; DOI: 10.1016/j.conrel.2004010.010.]Search in Google Scholar
[7. J. Varshosaz, M. Minaiyan and M. Forghanian, Prolonged hypocalcemic effect by pulmonary delivery of calcitonin loaded poly (methyl vinyl ether maleic acid) bioadhesive nanoparticles, Biomed. Res. Int. 2014, 1–13; DOI: 10.1155/2014/932615.10.1155/2014/932615395049424701588]Search in Google Scholar
[8. S. A. Shoyele and S. Cawthorne, Particle engineering techniques for inhaled biopharmaceuticals, Adv. Drug. Deliv. Rev.58 (2006) 1009–1029; DOI: 10.1016/j.addr.2006.07.010.10.1016/j.addr.2006.07.01017005293]Search in Google Scholar
[9. Y. F. Maa, P. A. Nguyen, T. Sweeney, S. J. Shire and C. C. Hsu, Protein inhalation powders: spray drying vs. spray freeze drying, Pharm. Res.16 (1999) 249–254; DOI: 10.1023/A:1018828425184.10.1023/A:1018828425184]Search in Google Scholar
[10. D. A. Edwards, J. Hanes, G. Caponetti, J. Hrkach, A. Ben-Jebria, M. L. Eskew, J. Mintzes, D. Deaver, N. Lotan and R. Langer, Large porous particles for pulmonary drug delivery, Science276 (1997) 1868–1872; DOI: 10.1126/science.276.5320.1868.10.1126/science.276.5320.18689188534]Search in Google Scholar
[11. Z. Yu, K. P. Johnston and R. O. Williams III, Spray freezing into liquid versus spray-freeze drying: Influence of atomization on protein aggregation and biological activity, Eur. J. Pharm. Sci.27 (2006) 9–18; DOI: 10.1016/j.ejps.2005.08.010.10.1016/j.ejps.2005.08.01016188431]Search in Google Scholar
[12. F. Depreter, G. Pilcer and K. Amighi, Inhaled proteins: Challenges and perspectives, Int. J. Pharm.447 (2013) 251–280; DOI: 10.1016/j.ijpharm.2013.02.031.10.1016/j.ijpharm.2013.02.03123499756]Search in Google Scholar
[13. N. R. Maddux, S. B. Joshi, D. B. Volkin, J. P. Ralston and C. R. Middaugh, Multidimensional methods for the formulation of biopharmaceuticals and vaccines, J. Pharm. Sci.100 (2011) 4171–4197; DOI: 10.1002/jps.22618.10.1002/jps.22618394919921647886]Search in Google Scholar
[14. T. Serno, R. Geidobler and G. Winter, Protein stabilization by cyclodextrins in the liquid and dried state, Adv. Drug Deliv. Rev.63 (2011) 1086–1106; DOI: 1016/j/addr.2011.08.003.10.1016/j.addr.2011.08.003]Search in Google Scholar
[15. J. Iwai, N. Ogawa, H. Nagase, T. Endo, T. Loftsson and H. Ueda, Effects of various cyclodextrins on the stability of freeze dried lactate dehydrogenase, J. Pharm. Sci.96 (2007) 3140–3143; DOI: 10.1002/jps.20847.10.1002/jps.20847]Search in Google Scholar
[16. K. Izutsu, S. Yoshioka and T. Terao, Stabilization of [beta]-galactosidase by amphiphilic additives during freeze-drying, Int. J. Pharm.90 (1993) 187–194; DOI: 10.1016/0378-5173(93)90190-Q.10.1016/0378-5173(93)90190-Q]Search in Google Scholar
[17. H. R. Costantino, L. Firouzabadian, C. Wu, K. G. Carrasquillo, K. Griebenow, S. E. Zale and M. A. Tracy, Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability, J. Pharm. Sci.91 (2002) 388–395; DOI: 10.1002/jps.10059.10.1002/jps.10059]Search in Google Scholar
[18. W. C. Johnson, Protein secondary structure and circular dichroism: a practical guide, Proteins7 (1990) 205–214; DOI: 10.1002/prot.340070302.10.1002/prot.340070302]Search in Google Scholar
[19. P. Manavalan and W. C. Johnson, Sensitivity of circular dichroism to protein tertiary structure class, Nature305 (1983) 831–832; DOI: 10.1038/305831a0.10.1038/305831a0]Search in Google Scholar
[20. H. R. Costantino, H. Culley, L. Chen, D. Morris, M. Houston, S. Roth, M. J. Phoenix, C. Foerder, J. S. Philo, T. Arakawa, L. Eideuschink, N. H. Andersen, G. Brandt and S. C. Quav, Development of calcitonin salmon nasal spray: similarity of peptide formulated in chlorobutanol compared to benzalkonium chloride as preservative, J. Pharm. Sci.98 (2009) 3691–3706; DOI: 10.1002/jps.21690.10.1002/jps.21690]Search in Google Scholar
[21. M. A. Capelle, R. Gurny and T. Arvinte, High throughput screening of protein formulation stability: practical considerations, Eur. J. Pharm. Biopharm.65 (2007) 131–148; DOI: 10.1016/j.ejpb.2006.09.009.10.1016/j.ejpb.2006.09.009]Search in Google Scholar
[22. J. T. Vivian and P. R. Callis, Mechanisms of tryptophan fluorescence shifts in proteins, Biophys. J.80 (2001) 2093–2109; DOI: 10.1016150006-349(01)76183-8.10.1016/S0006-3495(01)76183-8]Search in Google Scholar
[23. D. J. van Drooge, W. LJ. Hinrichs, B. H. J. Dickhoff, M. N. A. Elli, M. R. Visser, G. S. Zijlstra, W. Henddeik and H. W. Frijlink, Spray freeze drying to produce a stable Delta-9-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation, Eur. J. Pharm. Sci.26 (2005) 231–240; DOI: 10.1016/j.ejps.2005.06.007.10.1016/j.ejps.2005.06.00716084699]Search in Google Scholar
[24. S. A. Shoyele, N. Sivadas and S. A. Cryan, The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation, AAPS Pharmscitech. 12 (2011) 304–311; DOI: 10.1208/s12249-011-9585-2.10.1208/s12249-011-9585-2306637521271316]Search in Google Scholar
[25. D. A. Edwards, G. Caponetti, J. S. Hrkach, N. Lotan, J. Hanes and A. A. Ben-Jebria, Aerodynamically light particles for pulmonary drug delivery, U.S. Pat. 5874064. 23 Feb. 1999.]Search in Google Scholar
[26. Y. Kato, T. Matsuda, N. Kato and R. Nakamura, Maillard reaction of disaccharides with protein: suppressive effect of nonreducing and pyranoside groups on browning and protein polymerization, J. Agri. Food Chem.37 (1989) 1077–1081; DOI: 10.1021/jf00088a057.10.1021/jf00088a057]Search in Google Scholar
[27. W. Wang, Y. J. Wang and D. Q. Wang, Dual effects of Tween 80 on protein stability, Int. J. Pharm.347 (2008) 31–38; DOI: 10161j.ijpharm.2007.06.042.10.1016/j.ijpharm.2007.06.04217692480]Search in Google Scholar
[28. N. B. Bam, J. L. Cleland and T. W. Randolph, Molten globule intermediate of recombinant human growth hormone: stabilization with surfactants, Biotechnol. Prog.12 (1996) 801–809; DOI: 10.1021/bp960068b.10.1021/bp960068b8983207]Search in Google Scholar